Utilizing the ischemic stroke model of middle cerebral artery occlusion (MCAO), we tested the impact of EP1 pharmacological blockade or EP1 genetic deletion on neurovascular injury after ischemia. This evidence concerns the gene PTGER1 and medical procedure.